These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28820752)

  • 21. Antimicrobial management of sepsis and septic shock.
    Sharma S; Kumar A
    Clin Chest Med; 2008 Dec; 29(4):677-87, ix. PubMed ID: 18954702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing antimicrobial therapy in sepsis and septic shock.
    Kumar A
    Crit Care Clin; 2009 Oct; 25(4):733-51, viii. PubMed ID: 19892250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating endotoxin during initial antibiotic treatment of severe gram-negative bacteremic infections.
    Maury E; Barakett V; Blanchard H; Guitton C; Fitting C; Vassal T; Chauvin P; Guidet B; Offenstadt G
    J Infect Dis; 1998 Jul; 178(1):270-3. PubMed ID: 9652453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model.
    Cirioni O; Giacometti A; Ghiselli R; Mocchegiani F; Fineo A; Orlando F; Del Prete MS; Rocchi M; Saba V; Scalise G
    Antimicrob Agents Chemother; 2002 Jan; 46(1):101-4. PubMed ID: 11751118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial therapy of sepsis and septic shock--when are two drugs better than one?
    Abad CL; Kumar A; Safdar N
    Crit Care Clin; 2011 Apr; 27(2):e1-27. PubMed ID: 21440195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
    Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
    J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study.
    Kumar A; Safdar N; Kethireddy S; Chateau D
    Crit Care Med; 2010 Aug; 38(8):1651-64. PubMed ID: 20562695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy for septic shock: considerations for antibiotic stewardship.
    Mehta SA; Phillips MS
    Crit Care Med; 2011 Mar; 39(3):608-9; author reply 609. PubMed ID: 21330873
    [No Abstract]   [Full Text] [Related]  

  • 29. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.
    Al-Jasser AM
    Ann Clin Microbiol Antimicrob; 2006 Sep; 5():23. PubMed ID: 16978420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapies for shock associated with gram-negative sepsis?
    Ludbrook J
    Aust N Z J Surg; 1992 Dec; 62(12):913-5. PubMed ID: 1456901
    [No Abstract]   [Full Text] [Related]  

  • 31. Gram-negative shock: approaches to treatment.
    Jacobson MA; Young LS
    J R Coll Physicians Lond; 1985 Oct; 19(4):214-7. PubMed ID: 4067894
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiotic therapy for gram-negative bacteremia.
    Calandra T; Cometta A
    Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Septic shock caused by Sphingomonas paucimobilis bacteremia in a patient with hematopoietic stem cell transplantation.
    Al-Anazi KA; Abu Jafar S; Al-Jasser AM; Al-Shangeeti A; Chaudri NA; Al Jurf MD; Al-Mohareb FI
    Transpl Infect Dis; 2008 Apr; 10(2):142-4. PubMed ID: 17605729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; Silvestri C; Bozzi A; Di Giulio A; Luzi C; Mangoni ML; Barra D; Saba V; Scalise G; Rinaldi AC
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2478-86. PubMed ID: 16801429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotic strategy during septic shock].
    Carlet J
    Presse Med; 2006 Mar; 35(3 Pt 2):528-32. PubMed ID: 16550154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
    PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Septic shock secondary to Elizabethkingia meningoseptica: A case report].
    Brandariz Núñez D; Rodríguez Pedreira P; Hernández Corredoira V; Puig Forcada J; Gurri Hernand FJ; Boix Boix AS
    Rev Esp Quimioter; 2019 Aug; 32(4):390-392. PubMed ID: 31327187
    [No Abstract]   [Full Text] [Related]  

  • 38. Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: where is the gap?
    Capp R; Chang Y; Brown DF
    J Emerg Med; 2011 Dec; 41(6):573-80. PubMed ID: 21371846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotics in sepsis.
    Bochud PY; Glauser MP; Calandra T;
    Intensive Care Med; 2001; 27 Suppl 1():S33-48. PubMed ID: 11307369
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination therapy for extensively-drug resistant gram-negative bacteria.
    Karaiskos I; Antoniadou A; Giamarellou H
    Expert Rev Anti Infect Ther; 2017 Dec; 15(12):1123-1140. PubMed ID: 29172792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.